«Fra-2, Fra-2, a new therapeutic target in lung cancer and its microenvironment». (PI21/01997) Instituto de Salud Carlos III. Principal Investigator: Álvaro Ucero. 01/01/2022- 31/12/2024. 135.520 €.
We use our own and third-party cookies to ensure the website works properly, measure usage, and improve our services. You can accept all cookies, reject non-essential cookies, or configure your preferences. Cookie policy
Configure cookies
Required for the website to work correctly. They cannot be disabled from this panel.
Help measure site usage and improve its content.
Allow advertising, campaign measurement, or ad personalization.
Store preferences or enable non-essential external content.